ERK activation by Ca2+ ionophores depends on Ca2+ entry in lymphocytes but not in platelets, and does not conduct membrane scrambling

Cellular and Molecular Life Sciences

Volumn 65, Issue 23, 2008, Pages 3861-3871

  Arachiche, A ^a,b   Badirou, I ^a   Dachary Prigent, J ^b   Garcin, I ^b   Geldwerth Feniger, D ^a   Kerbiriou Nabias, D ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM   (France)

Author keywords

B lymphocytes; Extracellular signal regulated kinase; Jurkat; Phosphatidylserine; Phospholipid scrambling; Platelet; Scott syndrome

Indexed keywords

CALCIUM IONOPHORE; MITOGEN ACTIVATED PROTEIN KINASE; CALCIUM; IONOPHORE; PHOSPHOLIPID;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPHOCYTE; THROMBOCYTE; COMPARATIVE STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; LEUKEMIA CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOOD PLATELETS; BLOTTING, WESTERN; CALCIUM; CELL MEMBRANE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HUMANS; IONOPHORES; JURKAT CELLS; LYMPHOCYTES; MICROSCOPY, FLUORESCENCE; PHOSPHOLIPIDS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 57349104048     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8339-0     Document Type: Article

References (50)

1. Bevers, E. M., Comfurius, P. and Zwaal, R. F. (1983) Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta 736, 57-66.
2. Schlegel, R. A. and Williamson, P. (2001) Phosphatidylserine, a death knell. Cell Death Differ. 8, 551-563.
3. Adayev, T., Estephan, R., Meserole, S., Mazza, B., Yurkow, E. J. and Banerjee, P. (1998) Externalization of phosphatidylserine may not be an early signal of apoptosis in neuronal cells, but only the phosphatidylserine- displaying apoptotic cells are phagocytosed by microglia. J. Neurochem. 71, 1854-1864.
4. Comfurius, P., Senden, J. M., Tilly, R. H., Schroit, A. J., Bevers, E. M. and Zwaal, R. F. (1990) Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim. Biophys. Acta 1026, 153-160.
5. Dachary-Prigent, J., Freyssinet, J. M., Pasquet, J. M., Carron, J. C. and Nurden, A. T. (1993) Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 81, 2554-2565.
6. Weiss, H. J., Vicic, W. J., Lages, B. A. and Rogers, J. (1979) Isolated deficiency of platelet procoagulant activity. Am. J. Med. 67, 206-213.
7. Sims, P. J., Wiedmer, T., Esmon, C. T., Weiss, H. J. and Shattil, S. J. (1989) Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasmamembrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J. Biol. Chem. 264, 17049-17057.
8. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: A study of the red blood cells of Scott syndrome. Blood 79, 380-388.
9. Kojima, H., Newton-Nash, D., Weiss, H. J., Zhao, J., Sims, P. J. and Wiedmer, T. (1994) Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J. Clin. Invest. 94, 2237-2244.
10. Toti, F., Satta, N., Fressinaud, E., Meyer, D. and Freyssinet, J. M. (1996) Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87, 1409-1415.
11. Munnix, I. C., Harmsma, M., Giddings, J. C., Collins, P. W., Feijge, M. A., Comfurius, P., Heemskerk, J. W. and Bevers, E. M. (2003) Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thromb. Haemost. 89, 687-695.
12. 2+ in Scott syndrome. Thromb. Haemost. 91, 412-415.
13. 2+ entry. Biochem. Biophys. Res. Commun. 327, 335-341.
14. Devaux, P. F., Lopez-Montero, I. and Bryde, S. (2006) Proteins involved in lipid translocation in eukaryotic cells. Chem. Phys. Lipids 141, 119-132.
15. Wolfs, J. L., Comfurius, P., Rasmussen, J. T., Keuren, J. F., Lindhout, T., Zwaal, R. F. and Bevers, E. M. (2005) Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell. Mol. Life Sci. 62, 1514-1525.
16. Elliott, J. I., Sardini, A., Cooper, J. C., Alexander, D. R., Davanture, S., Chimini, G. and Higgins, C. F. (2006) Phosphatidylserine exposure in Blymphocytes: A role for lipid packing. Blood 108, 1611-1617.
17. Wurth, G. A. and Zweifach, A. (2002). Evidence that cytosolic calcium increases are not sufficient to stimulate phospholipid scrambling in human T-lymphocytes. Biochem. J. 362, 701-708
18. Keuren, J. F., Wielders, S. J., Ulrichts, H., Hackeng, T., Heemskerk, J. W., Deckmyn, H., Bevers, E. M. and Lindhout, T. (2005) Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler. Thromb. Vasc. Biol. 25, 1499-1505.
19. Kunzelmann-Marche, C., Freyssinet, J. M. and Martinez, M. C. (2002) Loss of plasma membrane phospholipid asymmetry requires raft integrity. Role of transient receptor potential channels and ERK pathway. J. Biol. Chem. 277, 19876-19881.
20. Murphy, L. O. and Blenis, J. (2006) MAPK signal specificity: The right place at the right time. Trends Biochem. Sci. 31, 268-275.
21. Li, Z., Xi, X. and Du, X. (2001) A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin αIIbβ3. J. Biol. Chem. 276, 42226-42232.
22. Pawlowski, M., Ragab, A., Rosa, J. P. and Bryckaert, M. (2002) Selective dephosphorylation of the threonine(183) residue of ERK2 upon αllbβ3 engagement in platelets. FEBS Lett. 521, 145-151.
23. Oury, C., Toth-Zsamboki, E., Vermylen, J. and Hoylaerts, M. F. (2002) P2X1-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood 100, 2499-2505.
24. Oury, C., Daenens, K., Hu, H., Toth-Zsamboki, E., Bryckaert, M. and Hoylaerts, M. F. (2006) ERK2 activation in arteriolar and venular murine thrombosis: Platelet receptor GPIb vs. P2X1. J. Thromb. Haemost. 4, 443-452.
25. Papkoff, J., Chen, R. H., Blenis, J. and Forsman, J. (1994) p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol. Cell. Biol. 14, 463-472.
26. Borsch-Haubold, A. G., Kramer, R. M. and Watson, S. P. (1996) Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets. Biochem. J. 318, 207-212.
27. Rosado, J. A. and Sage, S. O. (2001) Role of the ERK pathway in the activation of store-mediated calcium entry in human platelets. J. Biol. Chem. 276, 15659-15665.
28. Nadal-Wollbold, F., Pawlowski, M., Levy-Toledano, S., Berrou, E., Rosa, J. P. and Bryckaert, M. (2002) Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett. 531, 475-482.
29. McNicol, A. and Jackson, E. C. (2003) Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem. Pharmacol. 65, 1243-1250.
30. Yacoub, D., Theoret, J. F., Villeneuve, L., Abou-Saleh, H., Mourad, W., Allen, B. G. and Merhi, Y. (2006) Essential role of protein kinase C delta in platelet signaling, αIIbβ3 activation, and thromboxane A2 release. J. Biol. Chem. 281, 30024-30035.
31. Williamson, P., Christie, A., Kohlin, T., Schlegel, R. A., Comfurius, P., Harmsma, M., Zwaal, R. F. and Bevers, E. M. (2001) Phospholipid scramblase activation pathways in lymphocytes. Biochemistry 40, 8065-8072.
32. Balasubramanian, K., Mirnikjoo, B. and Schroit, A. J. (2007) Regulated externalization of phosphatidylserine at the cell surface: Implications for apoptosis. J. Biol. Chem. 282, 18357-18364.
33. 2+ transport properties of ionophores A23187, ionomycin, and 4-BrA23187 in a well defined model system. Biophys. J. 66, 1678-1693.
34. Schote, U. and Seelig, J. (1998) Interaction of the neuronal marker dye FM1-43 with lipid membranes. Thermodynamics and lipid ordering. Biochim. Biophys. Acta 1415, 135-146.
35. Zweifach, A. (2000) FM1-43 reports plasma membrane phospholipid scrambling in T-lymphocytes. Biochem. J. 349, 255-260.
36. Cousin, M. A. (2008) Use of FM1-43 and other derivatives to investigate neuronal function. In: Current Protocols in Neuroscience, Chapter 2, Unit 2 6, Wiley Interscience, New York.
37. Pouyssegur, J., Volmat, V. and Lenormand, P. (2002) Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 64, 755-763.
38. 2+ action potential channels by the MEK inhibitor PD98059. Exp. Cell Res. 260, 175-179.
39. Roberts, M. L. and Cooper, N. R. (1998) Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240, 93-99.
40. Franklin, R. A., Atherfold, P. A. and McCubrey, J. A. (2000) Calcium-induced ERK activation in human T lymphocytes occurs via p56Lck and CaM-kinase. Mol. Immunol. 37, 675-683.
41. Morrill, G. A. and Robbins, E. (1967) The role of calcium in the regulation of the steady-state levels of sodium and potassium in the HeLa cell. J. Gen. Physiol. 50, 781-792.
42. + exchanger in membrane phosphatidylserine exposure during human platelet activation. Biochim. Biophys. Acta 1761, 195-204.
43. Dedkova, E. N., Sigova, A. A. and Zinchenko, V. P. (2000) Mechanism of action of calcium ionophores on intact cells: Ionophore-resistant cells. Membr. Cell Biol. 13, 357-368.
44. Martin, S. W., Butcher, A. J., Berrow, N. S., Richards, M. W., Paddon, R. E., Turner, D. J., Dolphin, A. C., Sihra, T. S. and Fitzgerald, E. M. (2006). Phosphorylation sites on calcium channel α1 and β subunits regulate ERK-dependent modulation of neuronal N-type calcium channels. Cell Calcium. 39, 275-292.
45. Kohno, M. and Pouyssegur, J. (2006) Targeting the ERK signaling pathway in cancer therapy. Ann. Med. 38, 200-211.
46. Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., Rolland, F., Demkow, T., Hutson, T. E., Gore, M., Freeman, S., Schwartz, B., Shan, M., Simantov, R. and Bukowski, R. M. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N. Engl. J. Med. 356, 125-134.
47. Zhang, W., Konopleva, M., Shi, Y. X., McQueen, T., Harris, D., Ling, X., Estrov, Z., Quintas-Cardama, A., Small, D., Cortes, J. and Andreeff, M. (2008) Mutant FLT3: A direct target of sorafenib in acute myelogenous leukemia. J. Natl. Cancer Inst. 100, 184-198.
48. Elliott, J. I. and Higgins, C. F. (2003) IKCa1 activity is required for cell shrinkage, phosphatidylserine translocation and death in T lymphocyte apoptosis. EMBO Rep. 4, 189-194.
49. Taylor, S. R., Gonzalez-Begne, M., Dewhurst, S., Chimini, G., Higgins, C. F., Melvin, J. E. and Elliott, J. I. (2008) Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J. Immunol. 180, 300-308.
50. Wolfs, J. L., Wielders, S. J., Comfurius, P., Lindhout, T., Giddings, J. C., Zwaal, R. F. and Bevers, E. M. (2006) Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel. Blood 108, 2223-2228.